Market Movers: CVS Announces Split, ABB Robotics Deal Blocked, Palantir Surges on Midterm Tailwind

The Quick Take

• CVS Health announces a corporate split — separating insurance/pharmacy benefits from retail health, following a strategy similar to GE and J&J's breakups
• ABB's robotics division acquisition attempt is blocked — likely by competition regulators concerned about industrial automation sector concentration
• Palantir Technologies surges as midterm election results perceived as positive for defence and government technology spending

November 5, 2026 delivered a triple-header of corporate and market events across three distinct sectors. CVS Health's announced corporate split represents the continuation of a broad US conglomerate unbundling trend — following GE's breakup into three companies, Johnson & Johnson's separation of its consumer health division as Kenvue, and 3M's healthcare spin-off as Solventum. CVS, which combines a pharmacy benefits manager (Caremark), health insurer (Aetna), and retail pharmacy chain, has faced persistent investor pressure to separate these businesses whose valuations are compressed by the complexity of running regulated insurance, PBM, and retail operations under one roof.

ABB's blocked robotics acquisition represents a significant setback for the Swiss industrial conglomerate's expansion strategy in a sector it already dominates through its market-leading robotics division. Competition regulators — most likely the European Commission or the US DOJ/FTC — appear to have determined that the proposed acquisition would create excessive concentration in industrial automation and robotics, a market already controlled by a small number of global players including ABB, Fanuc, KUKA, and Yaskawa. The block signals that competition authorities are increasingly attentive to consolidation in AI-adjacent industrial automation markets, raising the bar for future M&A in the sector.

Palantir's surge following the midterm elections reflects the market's reading of the congressional outcome as favourable for the defence and government technology sector. Palantir, whose revenue is heavily weighted toward US government contracts — including significant relationships with the Department of Defence, CIA, and other intelligence agencies — benefits from political environments that prioritise defence spending and government modernisation. A congressional composition that is perceived as supportive of continued or expanded defence appropriations is a direct positive catalyst for Palantir's government segment, which is the company's highest-margin and most strategically defensible revenue stream.

Synthesized from 1 source covering CVS, ABB, and Palantir corporate events on November 5, 2026.